Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial
Mohammadreza Shalbafan(Iran University of Medical Sciences), Shahin Akhondzadeh(Roozbeh Hospital), Payam Mohammadinejad(Roozbeh Hospital), Seyed Vahid Shariat(Iran University of Medical Sciences), Kaveh Alavi(Iran University of Medical Sciences), Neda Askari(Roozbeh Hospital), Atefeh Zeinoddini(Massachusetts General Hospital), Masoud Salehi(Iran University of Medical Sciences)
Cited by 69
Related Papers
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
|BMC Public Health|2021|621
A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence–Powered Ultrasound for Improving Clinical Workflow
|Journal of the American College of Radiology|2019|319
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151